Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Sarcoma

Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study

Joonha Kwon, Jun Hyeong Lee, Young Han Lee, Jeeyun Lee, Jin-Hee Ahn, Se Hyun Kim, Seung Hyun Kim, Tae Il Kim, Kum-Hee Yun, Young Suk Park, Jeong Eun Kim, Kyu Sang Lee, Jung Kyoon Choi, Hyo Song Kim

Cancer Res Treat. 2022;54(4):1240-1255. Published online January 17, 2022 DOI: https://doi.org/10.4143/crt.2021.1194

Web of Science 4 Crossref 4

Factors Influencing Imatinib-Induced Hepatotoxicity

Ji Min Han, Jeong Yee, Yoon Sook Cho, Hye Sun Gwak

Cancer Res Treat. 2020;52(1):181-188. Published online June 26, 2019 DOI: https://doi.org/10.4143/crt.2019.131

Web of Science 14 Crossref 12

Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor

Dong-Hoe Koo, Min-Hee Ryu, Kyoung-Mee Kim, Han-Kwang Yang, Akira Sawaki, Seiichi Hirota, Jie Zheng, Bo Zhang, Chin-Yuan Tzen, Chun-Nan Yeh, Toshirou Nishida, Lin Shen, Li-Tzong Chen, Yoon-Koo Kang

Cancer Res Treat. 2016;48(4):1155-1166. Published online June 24, 2016 DOI: https://doi.org/10.4143/crt.2016.187

Web of Science 137 Crossref 123

A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets

Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer

Cancer Res Treat. 2016;48(3):1120-1129. Published online February 12, 2016 DOI: https://doi.org/10.4143/crt.2015.436

Web of Science 8 Crossref 8

Effect on Cell Cycle Progression by N-Myc Knockdown in SK-N-BE(2) Neuroblastoma Cell Line and Cytotoxicity with STI-571 Compound

Un-Young Yu, Je-Eun Cha, Sun-Young Ju, Kyung-Ah Cho, Eun-Sun Yoo, Kyung-Ha Ryu, So-Youn Woo

Cancer Res Treat. 2008;40(1):27-32. Published online March 31, 2008 DOI: https://doi.org/10.4143/crt.2008.40.1.27

Crossref 6

Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410 FAX: +82-2-792-1410 E-mail: journal@cancer.or.kr

About | Browse Articles | Current Issue | For Authors and Reviewers